🇺🇸 FDA
Patent

US 8674106

Alkynyl derivatives as modulators of metabotropic glutamate receptors

granted A61PA61P1/00A61P1/04

Quick answer

US patent 8674106 (Alkynyl derivatives as modulators of metabotropic glutamate receptors) held by Addex Pharma, S.A. expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Addex Pharma, S.A.
Grant date
Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61P, A61P1/00, A61P1/04, A61P25/00, A61P25/04